# PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A

> **NCT01198197** · EARLY_PHASE1 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 41 (actual)

## Conditions studied

- Pain
- Anxiety
- Depression

## Interventions

- **DRUG:** NOP-1A

## Key facts

- **NCT ID:** NCT01198197
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09-03
- **Primary completion:** —
- **Final completion:** 2014-02-28
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01198197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01198197, "PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01198197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*